Invention Grant
![4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1H-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor](/docs/US/2017-04-04/US09610284B2/abs.jpg.600x600.jpg)
- Patent Title: 4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1H-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor
-
Application No.: US15205372Application Date: 2016-07-08
-
Publication No.: US09610284B2Publication Date: 2017-04-04
- Inventor: Emmanuel Hubert Demont , Katherine Louise Jones , Robert J. Watson
- Applicant: GlaxoSmithKline LLC
- Applicant Address: US DE Wilmington
- Assignee: GlaxoSmithKline LLC
- Current Assignee: GlaxoSmithKline LLC
- Current Assignee Address: US DE Wilmington
- Agent Jane F. Djung; Kathryn A. Lutomski
- Priority: GB1114103.3 20110817
- Main IPC: A61K31/44
- IPC: A61K31/44 ; A61K31/4745 ; A61K31/437 ; C07D471/04
![4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1H-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor](/abs-image/US/2017/04/04/US09610284B2/abs.jpg.150x150.jpg)
Abstract:
Novel quinoline compounds pharmaceutical compositions containing such compounds and their use in therapy.
Public/Granted literature
Information query
